Trials / Completed
CompletedNCT03210571
Clinical Investigation of the eyeWatch Glaucoma Drainage Device
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Rheon Medical SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to test a new medical device, called the eyeWatch, used in filtering surgery for the treatment of glaucoma. This medical device has the following property: it allows better control of intraocular pressure in the initial postoperative phase by adjusting aqueous flow going through the device. The target criteria for the study are defined as: keeping intraocular pressure in target range; reducing the number of anti-glaucoma drugs; evaluating the number and type of postoperative complications. So far, this device has been already tested on 20 patients in Switzerland.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | eyeWatch system | The eyeWatch device is composed of an AGDD, a control unit and a draining plate |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2020-10-27
- Completion
- 2020-10-27
- First posted
- 2017-07-07
- Last updated
- 2021-10-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03210571. Inclusion in this directory is not an endorsement.